Blago Baychev

PharVision Capital was founded in 2020 in Chicago, IL as a systematic long-short, market-neutral, factor-neutral investment fund, capturing opportunities in the US-listed equity markets. PharVision is looking to deliver superior uncorrelated returns to investors, i.e. pure alpha, through a machine-plus-man approach. The team is utilizing proprietary quality data sources, sound economic reasoning, machine learning signal generation, vast computational resources and airtight portfolio risk-management to drive performance. The culture is centered around meritocracy, collaboration, innovation, creativity, overcommunication, urgency and relentless ambition to grow our intellectual competitive advantage.